Spyre Therapeutics Stock Investor Sentiment

SYRE Stock   27.75  0.08  0.29%   
About 62% of Spyre Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Spyre Therapeutics stock suggests that many investors are alarmed at this time. The current market sentiment, together with Spyre Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Spyre Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
few days ago at gurufocus.com         
Fairmount Funds Management LLCs Strategic Acquisition in Oruka Therapeutics Inc
Gurufocus Stories at Macroaxis
six days ago at thelincolnianonline.com         
Spyre Therapeutics Shares Gap Down Time to Sell?
news
over a week ago at finance.yahoo.com         
Spyre Therapeutics Announces Pricing of 200 Million Public Offering of Common Stock
Yahoo News
over a week ago at investing.com         
Spyre Therapeutics revises net loss per share calculations
Investing News at Macroaxis
over a week ago at finance.yahoo.com         
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock and Pre-Funded Warrants
Yahoo News
over a week ago at seekingalpha.com         
Spyre Therapeutics announces proposed secondary offering
seekingalpha News
over a week ago at gurufocus.com         
Perceptive Advisors LLC Reduces Stake in Spyre Therapeutics Inc
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Deep Track Capital, LP Adjusts Stake in Spyre Therapeutics Inc
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
FMR LLC Acquires Additional Shares in Spyre Therapeutics Inc
Gurufocus Stories at Macroaxis
over two weeks ago at investing.com         
Spyre shares target raised to 71 on positive trial data
Investing News at Macroaxis
over two weeks ago at investing.com         
Spyre Therapeutics director Jeffrey Albers sells 246,312 in stock
Investing News at Macroaxis
over two weeks ago at finance.yahoo.com         
Spyre Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Yahoo News
over two weeks ago at finance.yahoo.com         
Spyre Therapeutics Q3 Earnings Snapshot
Yahoo News
over two weeks ago at www.macroaxis.com         
Disposition of 6700 shares by Albers Jeffrey W. of Spyre Therapeutics at 36.7631 subject to Rule 16b...
Macroaxis News
over three weeks ago at finance.yahoo.com         
Selenis and Syre Partner to Establish Textile-to-Textile Recycling Plant in NorthCarolina
Yahoo News
Far too much social signal, news, headlines, and media speculation about Spyre Therapeutics that are available to investors today. That information is available publicly through Spyre media outlets and privately through word of mouth or via Spyre internal channels. However, regardless of the origin, that massive amount of Spyre data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Spyre Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Spyre Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Spyre Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Spyre Therapeutics alpha.

Spyre Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Spyre Stock analysis

When running Spyre Therapeutics' price analysis, check to measure Spyre Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spyre Therapeutics is operating at the current time. Most of Spyre Therapeutics' value examination focuses on studying past and present price action to predict the probability of Spyre Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spyre Therapeutics' price. Additionally, you may evaluate how the addition of Spyre Therapeutics to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency